Merck & Co. (MRK) Reports Q4 Adj-EPS of 88c, Beats by 5c; Guides FY11

February 3, 2011 7:03 AM EST
Merck & Co. Inc. (NYSE: MRK) reported Q4 EPS of $0.88, ex-items, $0.05 better than the analyst estimate of $0.83. Revenue for the quarter came in at $12.1 billion versus the consensus estimate of $11.53 billion.

Merck & Co. Inc. sees FY11 EPS of $3.64-$3.74, versus the consensus of $3.82. Merck & Co. Inc. sees FY11 revenue up low-mid single digits.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Earnings, Guidance, Hot Earnings, Hot Guidance, Hot List